Shou-Jiang Gao focuses on Kaposi's sarcoma-associated herpesvirus, Virology, Lytic cycle, Cancer research and Virus. His work deals with themes such as Plasmid, Green fluorescent protein, Molecular biology, Primary effusion lymphoma and Gammaherpesvirinae, which intersect with Kaposi's sarcoma-associated herpesvirus. His Virology research integrates issues from Antibody, Gene and Kaposi's sarcoma.
Shou-Jiang Gao interconnects Seroconversion and Immunology in the investigation of issues within Kaposi's sarcoma. His work carried out in the field of Lytic cycle brings together such families of science as Virus latency, Viral replication, Immediate early protein and Bacterial artificial chromosome. His studies in Cancer research integrate themes in fields like Cell culture, Cell, Carcinogenesis, Epstein–Barr virus and Selectin.
His primary areas of investigation include Virology, Kaposi's sarcoma-associated herpesvirus, Cancer research, Lytic cycle and Cell biology. The various areas that Shou-Jiang Gao examines in his Virology study include Serology, Antibody and Gene. His Kaposi's sarcoma-associated herpesvirus research incorporates elements of Kaposi's sarcoma, Molecular biology, Primary effusion lymphoma and Gammaherpesvirinae.
His Cancer research research is multidisciplinary, incorporating perspectives in Carcinogenesis, Cell cycle checkpoint, microRNA and Signal transduction. Shou-Jiang Gao combines subjects such as Virus latency, Viral replication, RNA, Immediate early protein and Transactivation with his study of Lytic cycle. His study in Cell biology is interdisciplinary in nature, drawing from both Autophagy and Viral entry.
His main research concerns Cancer research, Angiogenesis, Carcinogenesis, Cell culture and Cell biology. His Cancer research research is multidisciplinary, incorporating elements of Cancer cell, Protein deacetylase activity, microRNA and Mechanism of action. His Angiogenesis study integrates concerns from other disciplines, such as Protein kinase B, Signal transduction, Ubiquitin ligase and Mdm2.
His studies deal with areas such as Virus and Kaposi's sarcoma-associated herpesvirus as well as Cancer. He conducts interdisciplinary study in the fields of Kaposi's sarcoma-associated herpesvirus and Angiopoietin 2 through his research. His Coinfection study introduces a deeper knowledge of Virology.
Shou-Jiang Gao mainly focuses on Cancer research, Carcinogenesis, microRNA, Primary effusion lymphoma and Cell biology. His Cancer research research incorporates themes from Cancer, IRF1, Ubiquitin ligase and Motility. His Carcinogenesis research includes elements of Angiogenesis, Neovascularization, Downregulation and upregulation, Mdm2 and Proteasome.
Shou-Jiang Gao has included themes like DNMT1, DNA methylation, RNA, Small interfering RNA and Interferon regulatory factors in his microRNA study. His Primary effusion lymphoma study is associated with Cell culture. His Cell biology research is multidisciplinary, relying on both Cleavage, CRISPR, Apoptosis, Endonuclease and Proline dehydrogenase.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
KSHV antibodies among Americans, Italians and Ugandans with and without Kaposi's sarcoma.
Shou-Jiang Gao;Lawrence Kingsley;Ming Li;Wei Zheng.
Nature Medicine (1996)
Primary characterization of a herpesvirus agent associated with Kaposi's sarcomae.
Patrick S. Moore;Shou Jiang Gao;Geraldina Dominguez;Ethel Cesarman.
Journal of Virology (1996)
Seroconversion to antibodies against Kaposi's sarcoma-associated herpesvirus-related latent nuclear antigens before the development of Kaposi's sarcoma
Shou Jiang Gao;Lawrence Kingsley;Donald R. Hoover;Thomas J. Spira.
The New England Journal of Medicine (1996)
Prevalence of Kaposi's sarcoma associated herpesvirus infection measured by antibodies to recombinant capsid protein and latent immunofluorescence antigen
G. R. Simpson;T. F. Schulz;D. Whitby;P. M. Cook.
The Lancet (1996)
The 222- to 234-kilodalton latent nuclear protein (LNA) of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) is encoded by orf73 and is a component of the latency-associated nuclear antigen.
L Rainbow;G M Platt;G R Simpson;R Sarid.
Journal of Virology (1997)
FLIP-mediated autophagy regulation in cell death control
Jong-Soo Lee;Qinglin Li;June-Yong Lee;Sun-Hwa Lee.
Nature Cell Biology (2009)
KSHV ORF K9 (vIRF) is an oncogene which inhibits the interferon signaling pathway
Shou-Jiang Gao;Chris Boshoff;Sukhanya Jayachandra;Robin A Weiss.
Regulation of NF-kappaB inhibitor IkappaBalpha and viral replication by a KSHV microRNA.
Xiufen Lei;Zhiqiang Bai;Fengchun Ye;Jianping Xie.
Nature Cell Biology (2010)
Antibodies to butyrate-inducible antigens of Kaposi's sarcoma-associated herpesvirus in patients with HIV-1 infection.
George Miller;Michael O. Rigsby;Lee Heston;Elizabeth Grogan.
The New England Journal of Medicine (1996)
Efficient Infection by a Recombinant Kaposi's Sarcoma-Associated Herpesvirus Cloned in a Bacterial Artificial Chromosome: Application for Genetic Analysis
Fu Chun Zhou;Yan Jin Zhang;Jian Hong Deng;Xin Ping Wang.
Journal of Virology (2002)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: